Top Markets
Coin of the day
Poniard Pharmaceuticals, Inc. Poniard Pharmaceuticals, Inc.

Poniard Pharmaceuticals, Inc.

PARD
주식 순위 #42764
Poniard Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the... Poniard Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the discovery and market introduction of cancer treatments. Its flagship product candidate, Picoplatin, is a platinum-based therapy targeting various cancer types, such as small cell lung, colorectal, prostate, and ovarian cancers. The company has advanced Picoplatin through several clinical stages, including a pivotal Phase III SPEAR trial for small cell lung cancer patients in a second-line treatment setting. Furthermore, Phase II studies investigated Picoplatin as an initial therapy for metastatic colorectal cancer and hormone-refractory prostate cancer. An early-stage Phase I trial also examined an oral formulation of Picoplatin for solid tumors. Founded in 1984 as NeoRx Corporation, the company rebranded to Poniard Pharmaceuticals, Inc. in September 2006 and operates from its base in Seattle, Washington.
주가
$0.0001
마지막 동기화: 2026-08-11
시가총액
$150.00
변동 (1일)
0.00%
변동 (1년)
0.00%
국가
US
거래 Poniard Pharmaceuticals, Inc. (PARD)

카테고리

Poniard Pharmaceuticals, Inc. (PARD)의 주식 분할 이력
Poniard Pharmaceuticals, Inc. 주식 (심볼: PARD)은 총 0회의 주식 분할을 거쳤습니다.
가장 최근의 분할은 Aug 12, 2026에 발생했습니다.
Aug 12, 2026 이전에 매수한 PARD 주식 1주는 현재 0주의 PARD 주식에 해당합니다.
주식 분할 목록
연도 주식 분할 배수 누적 배수
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 주식 분할
회사 주식 분할 횟수 누적 배수 국가
1 x2
US
0 -
NL
0 -
CH
0 -
BE
0 -
KR